These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Yarker YE, Goa KL, Fitton A. Drugs Aging; 1995 Mar; 6(3):243-62. PubMed ID: 7620236 [Abstract] [Full Text] [Related]
7. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women. Goode PS, Burgio KL, Locher JL, Umlauf MG, Lloyd LK, Roth DL. J Am Geriatr Soc; 2002 May; 50(5):808-16. PubMed ID: 12028165 [Abstract] [Full Text] [Related]
8. Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity. Lehtoranta K, Tainio H, Lukkari-Lax E, Hakonen T, Tammela TL. Scand J Urol Nephrol; 2002 Feb; 36(1):18-24. PubMed ID: 12002352 [Abstract] [Full Text] [Related]
9. Clinical reevaluation of the effect of oxybutynin chloride on uninhibited neurogenic and reflex neurogenic bladder. Kawabe K, Abe S, Kanda T, Tei K. Urol Int; 1986 Feb; 41(1):16-20. PubMed ID: 3962017 [Abstract] [Full Text] [Related]
10. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters. Humblet M, Verpoorten C, Christiaens MH, Hirche H, Jansen K, Buyse G, van Gool JD. Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114 [Abstract] [Full Text] [Related]
11. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children. Amark P, Bussman G, Eksborg S. Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251 [Abstract] [Full Text] [Related]
12. Detrusor overactivity in spina bifida: how long does it need to be treated? Ab E, Dik P, Klijn AJ, van Gool JD, de Jong TP. Neurourol Urodyn; 2004 Aug; 23(7):685-8. PubMed ID: 15382196 [Abstract] [Full Text] [Related]
13. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder. Goldenberg MM. Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730 [Abstract] [Full Text] [Related]
14. Oxybutynin chloride in the treatment of female idiopathic bladder instability. Results from double blind treatment. Riva D, Casolati E. Clin Exp Obstet Gynecol; 1984 Apr; 11(1-2):37-42. PubMed ID: 6370504 [Abstract] [Full Text] [Related]
18. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability. Halaska M, Ralph G, Wiedemann A, Primus G, Ballering-Brühl B, Höfner K, Jonas U. World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500 [Abstract] [Full Text] [Related]
19. The use of intravesical oxybutynin chloride in children with neurogenic bladder. Greenfield SP, Fera M. J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294 [Abstract] [Full Text] [Related]